The main goal of this research is to isolate, identify, and evaluate new anticancer compounds from field-collected and cultured blue-green algae (cyanobacteria). Extracts of blue-green algae will be screened for cytotoxicity against human epidermoid carcinoma of the nasopharynx cells (KB) and a mouse fibroblast cell line (NIH3T3) and for antineoplastic activity in vivo against murine P-388 lymphocytic leukemia and murine Lewis lung carcinoma. Using one of more of these bioassays to monitor the fractionation of active extracts, cytotoxic and/or antitumor compounds will be isolated from the algae and their molecular structures, including absolute stereo-chemistries, will be elucidated by a combination of chemical and physical methods. The pure active compounds will be evaluated in other murine tumor systems, viz. B16 melanoma, Ehrlich ascites carcinoma, and Rauscher viral leukemia, for potential use as chemotherapeutic agents in the treatment of human cancer. Mode of action studies will be carried out on the active compounds. Extracts of blue-green algae will also be screened for potential inhibitors of tumor promotion with two bioassays, viz. inhibition of human promyelocytic leukemia (HL-60) cell adhesion by a potent tumor promoter such as 12-O-tetradecanoylphorbol-13-acetate (TPA) and inhibition of specific binding of a potent tumor promoter such as TPA to receptors in a rat embryonic fibroblast cell line (CREF). Several derivatives and analogues of aplysiatoxin, a tumor promoter from the marine blue-green alga Lyngbya majuscula having the same potency as TPA, will be prepared for structure-activity studies and the eventual development of an anti-tumor-promoter (chemopreventitive). Finally antineoplastic agents from certain marine organisms, e.g. palytoxin from the coelenterate Palythoa toxica, will be further evaluated as potential chemotherapeutic drugs.

National Institute of Health (NIH)
National Cancer Institute (NCI)
Research Project (R01)
Project #
Application #
Study Section
Bio-Organic and Natural Products Chemistry Study Section (BNP)
Project Start
Project End
Budget Start
Budget End
Support Year
Fiscal Year
Total Cost
Indirect Cost
University of Hawaii
Schools of Arts and Sciences
United States
Zip Code
Magarvey, Nathan A; Beck, Zachary Q; Golakoti, Trimurtulu et al. (2006) Biosynthetic characterization and chemoenzymatic assembly of the cryptophycins. Potent anticancer agents from cyanobionts. ACS Chem Biol 1:766-79
Liang, Jian; Moore, Richard E; Moher, Eric D et al. (2005) Cryptophycins-309, 249 and other cryptophycin analogs: preclinical efficacy studies with mouse and human tumors. Invest New Drugs 23:213-24
Chaganty, Sreedhara; Golakoti, Trimurtulu; Heltzel, Carl et al. (2004) Isolation and structure determination of cryptophycins 38, 326, and 327 from the terrestrial cyanobacterium Nostoc sp. GSV 224. J Nat Prod 67:1403-6
Becker, Julia E; Moore, Richard E; Moore, Bradley S (2004) Cloning, sequencing, and biochemical characterization of the nostocyclopeptide biosynthetic gene cluster: molecular basis for imine macrocyclization. Gene 325:35-42
Williams, Philip G; Yoshida, Wesley Y; Moore, Richard E et al. (2004) Micromide and guamamide: cytotoxic alkaloids from a species of the marine cyanobacterium Symploca. J Nat Prod 67:49-53
Luesch, Hendrik; Hoffmann, Dietmar; Hevel, Joan M et al. (2003) Biosynthesis of 4-methylproline in cyanobacteria: cloning of nosE and nosF genes and biochemical characterization of the encoded dehydrogenase and reductase activities. J Org Chem 68:83-91
Williams, Philip G; Yoshida, Wesley Y; Quon, Michael K et al. (2003) The structure of Palau'amide, a potent cytotoxin from a species of the marine cyanobacterium Lyngbya. J Nat Prod 66:1545-9
Williams, Philip G; Luesch, Hendrik; Yoshida, Wesley Y et al. (2003) Continuing studies on the cyanobacterium Lyngbya sp.: isolation and structure determination of 15-norlyngbyapeptin A and lyngbyabellin D. J Nat Prod 66:595-8
Williams, Philip G; Yoshida, Wesley Y; Moore, Richard E et al. (2003) Novel iodinated diterpenes from a marine cyanobacterium and red alga assemblage. Org Lett 5:4167-70
Mooberry, Susan L; Leal, Rachel M; Tinley, Tina L et al. (2003) The molecular pharmacology of symplostatin 1: a new antimitotic dolastatin 10 analog. Int J Cancer 104:512-21

Showing the most recent 10 out of 42 publications